[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Nicole Baca\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":41},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100421079",false,"NCT04763109","Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence","Inclusion Criteria:\n\n* Between the ages of 5 and \\\u003C18 years at the start of study. If subject will turn 18 during the study, they will be allowed to enroll.\n* Clinically or molecularly confirmed diagnosis of NF-1. Subjects with mosaic\u002Fsegmental NF-1 also qualify for the study.\n\nExclusion Criteria:\n\n* Requiring sedation for imaging.\n* Implants and\u002For Devices: Mechanical, magnetic or electrical activated implants; Ferromagnetic implants and foreign bodies\n* Claustrophobia, problems being in enclosed spaces, or inability to lie facing upwards.\n* Allergy to animal dander or animal-instigated asthma.","ALL","5 Years","17 Years",{"count":18,"type":19},15,"ESTIMATED","INTERVENTIONAL",[22],"NA","This is a single arm pilot trial of a novel whole-body Magnetic Resonance Imaging paired with artificial intelligence intervention, to evaluate feasibility defined as scan-rescan reliability, and to estimate the positive predictive value of changes in Magnetic Resonance Imaging scans from baseline to 12-month visit using an Artificial Intelligence algorithm, among 15 pediatric patients with neurofibromatosis type 1 at Cedars-Sinai Medical Center.",[25],"Neurofibromatosis Type 1",[27,25,28],"Pediatric","magnetic resonance imaging","RECRUITING","2026-05-01",{"date":32,"type":33},"2026-05-07","ACTUAL",{"date":35,"type":33},"2022-07-08",{"date":37,"type":19},"2029-05",{"name":39,"class":40},"Nicole Baca","OTHER",""]